Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123570884 | 12357088 | 4 | F | 20160830 | 20160511 | 20160902 | PER | PHEH2016US011587 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160902 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123570884 | 12357088 | 1 | PS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.0625 MG (0.25 ML), QOD (WEEK 1-2) | 125290 | .25 | ML | SOLUTION FOR INJECTION | |||||||
| 123570884 | 12357088 | 2 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.125 MG (0.5 ML) FOR WEEK 3 TO 4, QOD | 125290 | .5 | ML | SOLUTION FOR INJECTION | |||||||
| 123570884 | 12357088 | 3 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.1875 MG (0.75 ML) FOR WEEK 5 TO 6, QOD | 125290 | .75 | ML | SOLUTION FOR INJECTION | |||||||
| 123570884 | 12357088 | 4 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.25 MG (1 ML) FOR WEEK 7 PLUS, QOD | 125290 | 1 | ML | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123570884 | 12357088 | 1 | Multiple sclerosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123570884 | 12357088 | Gait disturbance | |
| 123570884 | 12357088 | Injection site bruising | |
| 123570884 | 12357088 | Injection site erythema | |
| 123570884 | 12357088 | Injection site pain | |
| 123570884 | 12357088 | Liver function test increased | |
| 123570884 | 12357088 | Memory impairment | |
| 123570884 | 12357088 | Vascular injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |